KCM Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.91M Sell
15,066
-4,430
-23% -$560K 0.06% 162
2025
Q1
$2.49M Sell
19,496
-689
-3% -$88.1K 0.09% 139
2024
Q4
$2.67M Sell
20,185
-196
-1% -$25.9K 0.09% 135
2024
Q3
$2.97M Sell
20,381
-469
-2% -$68.3K 0.1% 135
2024
Q2
$2.86M Sell
20,850
-72
-0.3% -$9.88K 0.1% 125
2024
Q1
$2.87M Sell
20,922
-185
-0.9% -$25.4K 0.11% 126
2023
Q4
$2.87M Sell
21,107
-1,368
-6% -$186K 0.11% 125
2023
Q3
$2.75M Sell
22,475
-507
-2% -$62K 0.12% 127
2023
Q2
$2.92M Sell
22,982
-610
-3% -$77.4K 0.12% 131
2023
Q1
$3.05M Sell
23,592
-1,000
-4% -$129K 0.12% 133
2022
Q4
$3.23M Sell
24,592
-1,225
-5% -$161K 0.14% 122
2022
Q3
$3.02M Buy
25,817
+155
+0.6% +$18.1K 0.14% 124
2022
Q2
$3.02M Sell
25,662
-20,538
-44% -$2.42M 0.13% 125
2022
Q1
$6.02M Sell
46,200
-4,091
-8% -$533K 0.22% 98
2021
Q4
$7.68M Sell
50,291
-757
-1% -$116K 0.27% 86
2021
Q3
$8.25M Sell
51,048
-665
-1% -$108K 0.33% 70
2021
Q2
$8.46M Buy
51,713
+144
+0.3% +$23.6K 0.34% 68
2021
Q1
$7.76M Sell
51,569
-464
-0.9% -$69.9K 0.34% 68
2020
Q4
$7.88M Buy
52,033
+217
+0.4% +$32.9K 0.38% 65
2020
Q3
$7.02M Buy
51,816
+11,475
+28% +$1.55M 0.39% 59
2020
Q2
$5.51M Buy
40,341
+125
+0.3% +$17.1K 0.31% 75
2020
Q1
$4.33M Sell
40,216
-4,855
-11% -$523K 0.29% 77
2019
Q4
$5.43M Sell
45,071
-3,055
-6% -$368K 0.3% 85
2019
Q3
$4.79M Sell
48,126
-4,555
-9% -$453K 0.28% 90
2019
Q2
$5.75M Sell
52,681
-111
-0.2% -$12.1K 0.34% 82
2019
Q1
$5.9M Sell
52,792
-2,747
-5% -$307K 0.38% 73
2018
Q4
$5.36M Sell
55,539
-1,420
-2% -$137K 0.35% 74
2018
Q3
$6.95M Sell
56,959
-564
-1% -$68.8K 0.4% 66
2018
Q2
$6.32M Sell
57,523
-645
-1% -$70.8K 0.39% 67
2018
Q1
$6.21M Sell
58,168
-930
-2% -$99.3K 0.38% 70
2017
Q4
$6.31M Sell
59,098
-1,103
-2% -$118K 0.37% 71
2017
Q3
$6.69M Sell
60,201
-1,755
-3% -$195K 0.41% 70
2017
Q2
$6.4M Buy
61,956
+1,491
+2% +$154K 0.4% 72
2017
Q1
$5.91M Buy
60,465
+1,746
+3% +$171K 0.38% 71
2016
Q4
$5.19M Buy
58,719
+1,704
+3% +$151K 0.35% 80
2016
Q3
$5.5M Buy
57,015
+1,575
+3% +$152K 0.38% 75
2016
Q2
$4.76M Buy
55,440
+852
+2% +$73.1K 0.33% 88
2016
Q1
$4.75M Buy
54,588
+3,102
+6% +$270K 0.35% 84
2015
Q4
$5.81M Buy
51,486
+4,098
+9% +$462K 0.46% 61
2015
Q3
$4.79M Buy
47,388
+3,891
+9% +$393K 0.4% 76
2015
Q2
$5.35M Buy
43,497
+6,315
+17% +$777K 0.43% 65
2015
Q1
$4.26M Buy
37,182
+6,144
+20% +$703K 0.34% 88
2014
Q4
$3.14M Buy
31,038
+10,098
+48% +$1.02M 0.26% 111
2014
Q3
$1.91M Buy
20,940
+4,140
+25% +$378K 0.17% 155
2014
Q2
$1.44M Buy
16,800
+2,562
+18% +$219K 0.13% 189
2014
Q1
$1.12M Buy
14,238
+5,685
+66% +$448K 0.12% 210
2013
Q4
$647K Buy
+8,553
New +$647K 0.07% 258